SCHEMBL9824169

SCHEMBL9824169

Nc1nc2c(ncn2CCC(CO)COP(=O)([O-])O)c(=O)[nH]1.[Na+]

nearest known ligand 0.73

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 14/20 0.60
PNP P00491 3/20 0.54
TK1 P04183 1/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
CYP3A4 P08684 1/20 0.53
NFKB1 P19838 1/20 0.53
BLM P54132 1/20 0.53
VCP P55072 1/20 0.53
KMT2A Q03164 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HIF1A Q16665 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7196190 0.91 HPRT1 (0.58) HPRT1PNPTK1MEN1ALDH1A1
Ammonia Solution, Strong SCHEMBL5930250 0.90 HPRT1 (0.57) HPRT1PNPTK1MEN1ALDH1A1
SCHEMBL12732295 0.89 HPRT1 (0.57) HPRT1PNPTK1MEN1ALDH1A1
Penciclovir SCHEMBL454090 0.88 HPRT1 (0.66) HPRT1PNPTK1MEN1ALDH1A1
Penciclovir SCHEMBL4240104 0.88 HPRT1 (0.66) HPRT1PNPTK1MEN1ALDH1A1
SCHEMBL12800326 0.87 HPRT1 (0.57) HPRT1PNPTK1MEN1ALDH1A1
Penciclovir Triphosphate SCHEMBL1664402 0.87 POLG (0.65) HPRT1PNPTK1MEN1ALDH1A1
Penciclovir Triphosphate SCHEMBL30945294 0.87 POLG (0.65) HPRT1PNPTK1MEN1ALDH1A1
Penciclovir SCHEMBL3495 0.85 TK1 (0.70) HPRT1PNPTK1MEN1ALDH1A1
SCHEMBL15340416 0.84 HPRT1 (0.55) HPRT1PNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0141927-B1 ANTIVIRAL GUANINE DERIVATIVES BEECHAM GROUP PLC (GB) 1991-10-30 EP claimed
EP-0152316-B1 SUBSTITUTED BUTYL GUANINES AND THEIR UTILIZATION IN ANTIVIRAL COMPOSITIONS MERCK & CO. INC. (US) 1989-07-26 EP disclosed
US-4845084-A HERPES VIRUSES, AIDS MERCK & CO., INC. (US) 1989-07-04 US disclosed
EP-0152316-A1 Substituted butyl guanines and their utilization in antiviral compositions MERCK & CO. INC. (US) 1985-08-21 EP disclosed